Glenmark Pharmaceuticals U.S. > News

News

Press Releases

Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.

Glenmark Pharmaceuticals receives ANDA approval for Linezoid tablets, 600 mg

December 22, 2015

Glenmark Pharmaceuticals receives ANDA approval for Clotrimazole and Betamethasone Dipropionate Cream USP, 1%-0.05%

November 9, 2015

Glenmark Pharmaceuticals receives ANDA approval for Voriconazole Tablets, 50 mg and 200 mg

September 4, 2015

Glenmark Pharmaceuticals receives ANDA approval for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg-0.02 mg

August 19, 2015

News

Search Result :-

Is an investigational new drug that has not been approved for commercial distribution in the United States.

December 22, 2015
Glenmark Pharmaceuticals receives ANDA approval for Linezoid tablets, 600 mg

November 9, 2015
Glenmark Pharmaceuticals receives ANDA approval for Clotrimazole and Betamethasone Dipropionate Cream USP, 1%-0.05%

September 4, 2015
Glenmark Pharmaceuticals receives ANDA approval for Voriconazole Tablets, 50 mg and 200 mg

August 19, 2015
Glenmark Pharmaceuticals receives ANDA approval for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg-0.02 mg

US Media Contact

For media inquiries only, please contact Corporate Communications.
uscomms@glenmarkpharma.com

Investor Relations

For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.

POTASSIUM CHLORIDE EXTENDED RELEASE CAPSULES 750mg RECALL REIMBURSEMENT POLICY

Over-the-counter (OTC)

ACCESSIBLE PRODUCTS

Who We Are

Injectables

OUR GROWING LINE